Diluted EPS came in at $-0.22 (+29.0% YoY), beat the $-0.34 consensus by $0.12.
Trailing eight quarters through Q1 2025
Common questions about enVVeno Medical Corporation's Q1 2025 earnings report.
enVVeno Medical Corporation (NVNO) reported Q1 2025 earnings on April 30, 2025 before market open.
enVVeno Medical Corporation reported diluted EPS of $-0.22 for Q1 2025.
EPS beat the consensus estimate of $-0.34 by $0.12.
Compared to the same quarter a year prior, diluted EPS grew 29.0% from $-0.31.
You can read the 10-Q periodic report (0001641172-25-007908) directly on SEC EDGAR. The filing index links above go to sec.gov.